Menu
Home
GPcardio CVD, CKD & T2D About EPCCS About IPCCS NCD Academy EACH WONCA World 2025
EPCCS
About EPCCS Connected Societies GPcardio About IPCCS
Education
Lipid Management in ... Cardio Renal Update Cardiovascular Updat... The EU Cardiovascula... Cardiovascular Disea... Managing CV risk in ...
Resources
Practice Guidance Meeting reports STRATIFYHF Recent News Video updates WONCA World 2025
Literature
Left Atrial Appendag... 26 Mar. Novel cardiovascular... 26 Mar. Systemic Inflammatio... 24 Mar. Use of Coronary Arte... 16 Mar. 2026 ACC/AHA Guideli... 13 Mar. Off-label underdosin... 12 Mar. Semaglutide promotes... 9 Mar. Effect of baxdrostat... 7 Mar. More Literature

Feb. 16, 2021

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment

Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.

Thomas M Maddox, James L Januzzi, Larry A Allen et al. - Journal of the American College of Cardiology

The 2021 ACC Expert Consensus update addressed 10 pivotal questions on heart failure treatment optimization, integrating evidence for SGLT2 inhibitors across the ejection fraction spectrum, vericiguat in recently decompensated HFrEF, and practical implementation of quadruple therapy.

Source